Annual ROE
-4.98%
-11.86%-172.38%
31 December 2023
Summary:
Pharming Group NV annual return on equity is currently -4.98%, with the most recent change of -11.86% (-172.38%) on 31 December 2023. During the last 3 years, it has fallen by -30.08% (-119.84%). PHAR annual ROE is now -101.58% below its all-time high of 314.86%, reached on 31 December 2012.PHAR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-8.24%
-1.93%-30.59%
30 September 2024
Summary:
Pharming Group NV quarterly return on equity is currently -8.24%, with the most recent change of -1.93% (-30.59%) on 30 September 2024. Over the past year, it has increased by +2.63% (+24.20%). PHAR quarterly ROE is now -100.29% below its all-time high of 2883.23%, reached on 30 June 2012.PHAR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -172.4% | +24.2% |
| 3 y3 years | -119.8% | -170.2% |
| 5 y5 years | -107.8% | -116.6% |
PHAR ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -119.8% | at low | -153.2% | +24.2% |
| 5 y | 5 years | -107.8% | at low | -116.6% | +24.2% |
| alltime | all time | -101.6% | +98.8% | -100.3% | +99.7% |
Pharming Group NV ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -8.24%(+30.6%) |
| June 2024 | - | -6.31%(+21.1%) |
| Mar 2024 | - | -5.21%(+2.0%) |
| Dec 2023 | -4.98%(-172.4%) | -5.11%(-53.0%) |
| Sept 2023 | - | -10.87%(+33.0%) |
| June 2023 | - | -8.17%(+717.0%) |
| Mar 2023 | - | -1.00%(-114.5%) |
| Dec 2022 | 6.88%(-19.1%) | 6.90%(-55.5%) |
| Sept 2022 | - | 15.49%(+45.4%) |
| June 2022 | - | 10.65%(+87.8%) |
| Mar 2022 | - | 5.67%(-32.3%) |
| Dec 2021 | 8.50%(-66.1%) | 8.38%(-28.6%) |
| Sept 2021 | - | 11.74%(-35.5%) |
| June 2021 | - | 18.19%(-21.3%) |
| Mar 2021 | - | 23.10%(-10.4%) |
| Dec 2020 | 25.10%(-41.8%) | 25.79%(-24.6%) |
| Sept 2020 | - | 34.21%(-13.5%) |
| June 2020 | - | 39.54%(-4.7%) |
| Mar 2020 | - | 41.49%(-7.4%) |
| Dec 2019 | 43.14%(-32.1%) | 44.80%(-9.6%) |
| Sept 2019 | - | 49.56%(-1.6%) |
| June 2019 | - | 50.39%(-0.5%) |
| Mar 2019 | - | 50.64%(-17.8%) |
| Dec 2018 | 63.56%(-116.8%) | 61.64%(-166.9%) |
| Sept 2018 | - | -92.15%(-52.9%) |
| June 2018 | - | -195.51%(-48.1%) |
| Mar 2018 | - | -376.78%(-22.4%) |
| Dec 2017 | -379.45%(+465.3%) | -485.68%(+74.5%) |
| Sept 2017 | - | -278.27%(+27.8%) |
| June 2017 | - | -217.68%(+153.2%) |
| Mar 2017 | - | -85.98%(+8.0%) |
| Dec 2016 | -67.12% | -79.64%(+15.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2016 | - | -68.98%(+24.1%) |
| June 2016 | - | -55.57%(+18.5%) |
| Mar 2016 | - | -46.89%(+32.8%) |
| Dec 2015 | -34.92%(+7.6%) | -35.32%(-201.7%) |
| Sept 2015 | - | 34.73%(-28.5%) |
| June 2015 | - | 48.54%(-18.2%) |
| Mar 2015 | - | 59.37%(-252.0%) |
| Dec 2014 | -32.46%(-89.2%) | -39.06%(-86.5%) |
| Sept 2014 | - | -289.98%(-50.4%) |
| June 2014 | - | -584.55%(-80.3%) |
| Mar 2014 | - | -2969.52%(-233.4%) |
| Dec 2013 | -300.60%(-195.5%) | 2226.19%(+632.4%) |
| Sept 2013 | - | 303.95%(+23.2%) |
| June 2013 | - | 246.67%(-12.5%) |
| Mar 2013 | - | 281.84%(-14.1%) |
| Dec 2012 | 314.86%(-184.5%) | 328.18%(-36.9%) |
| Sept 2012 | - | 520.33%(-82.0%) |
| June 2012 | - | 2883.23%(-420.6%) |
| Mar 2012 | - | -899.43%(+163.6%) |
| Dec 2011 | -372.80%(-9.3%) | -341.22%(+7.3%) |
| Sept 2011 | - | -318.13%(+9.8%) |
| June 2011 | - | -289.78%(-28.1%) |
| Mar 2011 | - | -403.27%(+1.1%) |
| Dec 2010 | -410.89%(+63.3%) | -398.80%(+17.8%) |
| Sept 2010 | - | -338.58%(-20.5%) |
| June 2010 | - | -426.04%(+21.8%) |
| Mar 2010 | - | -349.79%(+48.2%) |
| Dec 2009 | -251.55%(+115.6%) | -235.96% |
| Dec 2008 | -116.69%(+105.0%) | - |
| Dec 2007 | -56.92%(+16.4%) | - |
| Dec 2006 | -48.91%(-21.3%) | - |
| Dec 2005 | -62.14% | - |
FAQ
- What is Pharming Group NV annual return on equity?
- What is the all time high annual ROE for Pharming Group NV?
- What is Pharming Group NV annual ROE year-on-year change?
- What is Pharming Group NV quarterly return on equity?
- What is the all time high quarterly ROE for Pharming Group NV?
- What is Pharming Group NV quarterly ROE year-on-year change?
What is Pharming Group NV annual return on equity?
The current annual ROE of PHAR is -4.98%
What is the all time high annual ROE for Pharming Group NV?
Pharming Group NV all-time high annual return on equity is 314.86%
What is Pharming Group NV annual ROE year-on-year change?
Over the past year, PHAR annual return on equity has changed by -11.86% (-172.38%)
What is Pharming Group NV quarterly return on equity?
The current quarterly ROE of PHAR is -8.24%
What is the all time high quarterly ROE for Pharming Group NV?
Pharming Group NV all-time high quarterly return on equity is 2883.23%
What is Pharming Group NV quarterly ROE year-on-year change?
Over the past year, PHAR quarterly return on equity has changed by +2.63% (+24.20%)